ArticleBioData mining2025
CatBoost with physics-based metaheuristics for thyroid cancer recurrence prediction.
Article in BioData mining, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Decision tree with randomized grid search-based hyperparameter tuning and optimal feature scaling for diabetes diagnosis.BMC bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid Cancer (TC) is the uncontrolled growth of carcinogenic cells in the thyroid gland, with a higher recurrence rate than other cancers. Early detection of TC recurrence (TCR) is crucial for timely intervention. This study develops machine-learning algorithms that reduce features while maintaining high performance. Previous studies on the Differentiated Thyroid Cancer Recurrence (DTCR) dataset struggled to improve performance with feature reduction, and misclassification causes remained unexplored. This work proposes three Physics-based Metaheuristic Algorithms (PBMHAs)—Energy Valley Optimization (EVOA), Equilibrium Optimization (EOA), and Electromagnetic Field Optimization (EFOA)—combined with the Categorical Boosting (CatBoost) classifier. SHAP is used to analyze feature importance. CatBoost without optimization (Only CB) achieved 95.83% Accuracy, 92.42% F-score, 96.29% Precision, and 89.27% Recall using all 16 features. After optimization, EVOA_CB reached 96.35% mean accuracy, while EOA_CB and EFOA_CB achieved 96.17%. EOA_CB excluded 11 less important features, and EFOA_CB attained the highest mean AUC of 0.994 with the lowest computational times. Additionally, this work provides insights into the factors contributing to misclassification. Using a 30:70 train-test split over 5 folds, EVOA_CB performed best on six selected features, with 96.35% Accuracy, 93.34% F-score, and 96.19% Precision. SHAP highlighted response, risk, and N as the most important features. These findings support early, efficient detection of TC recurrence with fewer features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.